News Release
New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet
January 21st, 2020
Cancer
Georgetown University’s cancer-focused work takes place at Georgetown Lombardi Comprehensive Cancer Center, the only National Cancer Institute (NCI)-designated Comprehensive Cancer Center in the Washington area.
Georgetown Lombardi serves as the research engine for MedStar Health, its clinical partner.
Georgetown Lombardi is also an NCI recognized consortium with John Theurer Cancer Center/Hackensack Meridian Health in Bergen County, New Jersey. The consortium reflects an integrated cancer research enterprise with scientists and physician-researchers from both locations.
Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational and clinical research, patient care, community education and outreach to service communities throughout the Washington region, while its consortium member John Theurer Cancer Center/Hackensack Meridian Health serves communities in northern New Jersey.
Current Cancer News
GUMC Stories
Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer
January 4th, 2020
News Release
Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice
December 30th, 2019
